Zoetis Inc.’s Stock Price Soars to $189.23, Marking a Robust 1.41% Increase

Zoetis Inc. (ZTS)

189.23 USD +2.64 (+1.41%) Volume: 2.71M

Get the latest on Zoetis Inc.’s stock price, currently standing at 189.23 USD, witnessing a positive surge of +1.41% this trading session with a trading volume of 2.71M. Despite a year-to-date dip of -4.12%, ZTS continues to be a valuable player in the stock market.

Latest developments on Zoetis Inc.

Recently, Zoetis stock has been in the spotlight with various events impacting its price movements. Jim Cramer expressed his positive sentiment towards Zoetis, stating that he likes the company very much. Additionally, the stock has seen a 1.4% increase since its last earnings report, indicating positive performance. Despite a bid denial in a racehorse death suit, Zoetis continues to attract investors, with TD Asset Management Inc boosting its holdings in the company. With the veterinary vaccines market growing rapidly, Zoetis remains a key player in the pet care industry, showing promising potential for future growth.

A look at Zoetis Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Zoetis has a positive long-term outlook. With a strong momentum score of 4, the company is showing good potential for growth and performance in the future. Additionally, Zoetis scored a 3 in both the Dividend and Growth categories, indicating stability and potential for increased returns for investors. While the company scored lower in Value and Resilience with scores of 2, its overall outlook remains optimistic.

Zoetis Inc. is a leading player in the animal health industry, focusing on developing and commercializing medicines and vaccines for both livestock and companion animals. With a presence in multiple regions across the globe, including North America, Europe, Africa, Asia, Australia, and Latin America, Zoetis is well-positioned to capitalize on the growing demand for animal health products. Investors can look forward to potential growth and stability from this established company in the long term.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma